Get The Alerts + Report

Twist Bioscience Corp [TWST]

Reporting date: 02/11/2026

⚠️ Neutral Insider Sale Detected

📝 What Happened

  • Insider: Cho Dennis; Laponis Adam
  • Role: Dennis Cho — Senior Vice President, Chief Legal Officer & Corporate Secretary; Adam Laponis — Chief Financial Officer
  • Company: Twist Bioscience Corp (TWST)
  • Transaction Date(s): 2026-02-11, 2026-02-12
  • Table I (Non-Derivative Securities)
    • Sale : 12,000 shares
    • Average Sale Price: $49.93; $50.00 (weighted avg: $49.97)
    • Total Value: ~$599,650 (aggregate proceeds of both sales)
    • Post-Transaction Direct Holdings: Dennis Cho — 138,581 shares; Adam Laponis — 130,031 shares
    • Indirect Holdings: None reported
    • 10b5-1 Plan Used? Yes — both transactions effected pursuant to Rule 10b5-1 plans

    📄 Summary

    Cho Dennis (Senior VP, Chief Legal Officer & Corporate Secretary) and Adam Laponis (Chief Financial Officer) at Twist Bioscience Corp (TWST), sold a combined 12,000 shares on February 11–12, 2026, at an average price of $49.97, realizing proceeds of about ~$599,650. After the transactions, they now hold Dennis Cho: 138,581 shares; Adam Laponis: 130,031 shares. For retail traders, this is a neutral event: pre-planned 10b5-1 sales, likely routine liquidity rather than new negative information.

    🔑 Interpretation

    • Type: Comp-related (pre-planned transactions under Rule 10b5-1 plans)
    • Disposition: Sold immediately pursuant to the 10b5-1 plans (transaction code S, disposition D)
    • Size Context: Modest sales relative to holdings — Cho sold ~5,000 (~3–4% of his pre-sale stake) and Laponis sold ~7,000 (~5% of his pre-sale stake); appears routine profit-taking/liquidity rather than a large-scale exit.
    • ATH Metric: Trades executed around ~$50.00; this is not obviously at an extreme all-time high or low in the stock’s history (trade price appears mid-range), so timing does not strongly suggest opportunistic selling at a peak or panic selling at a low based on the available price context.
    • Outlier Check: Not unusually large compared to typical insider 10b5-1 plan sales — amounts are modest and consistent with routine plan-based disposals.

    📊 Bullish or Bearish?

    Decide: Neutral

    Neutral. Both insiders executed pre-established 10b5-1 plan sales (net sells of 12,000 shares) which look like routine liquidity rather than a discretionary negative signal; the filings include prices and quantities so the data is complete for these transactions. Cluster activity cannot be determined from this filing alone.

    ✅ Bottom Line (Retail Takeaway)

    This transaction looks like routine profit-taking under pre-set 10b5-1 plans rather than a bearish signal. For retail traders, it’s likely noise — not a clear tradeable event unless accompanied by coordinated sales from multiple senior executives or material company news.